| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |